Síndrome de Sweet Induzido pela Carbamazepina
Resumo
.
Downloads
Referências
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-245. PMID: 7249508.
- Villarreal-Villarreal CD, Ocampo-Candiani J, Villarreal-Martínez A. Sweet Syndrome: A Review and Update. Actas Dermosifiliogr 2016; 107(5): 369-78. PMID: 26826881.
- Casarin Costa JR, Virgens AR, de Oliveira Mestre L, Dias NF, Samorano LP, Valente NYS, et al. Sweet Syndrome: Clinical Features, Histopathology, and Associations of 83 Cases. J Cutan Med Surg 2017; 21(3): 211-216. PMID: 28300447.
- Heath MS, Ortega-Loayza AG. Insights Into the Pathogenesis of Sweet's Syndrome. Front Immunol 2019; 12; 10:414. PMID: 30930894.
- Nelson CA, Noe MH, McMahon CM, Gowda A, Wu B, Ashchyan HJ, et al. Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center. J Am Acad Dermatol 2018; 78(2): 303-309.e4. PMID: 29107342.
Direitos de Autor (c) 2020 Revista da Sociedade Portuguesa de Dermatologia e Venereologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Todos os artigos desta revista são de acesso aberto sob a licença internacional Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0).
